For acquisition of majority stake
Dr Datsons Labs has received letter of interest between Mires B.V a European based Pharma Company (proposed acquirer) and Dr Datsons Labs (target Company) summarize their mutual interest in the acquirer buying the target Company.The acquirer proposed the enterprise valuation of the target Company is decided post due diligence.
The acquirer proposed to buy majority stake in the target company and the Company undertakes to take all necessary steps for the benefit of the stakeholders of the Company.
Powered by Capital Market - Live News
